Federico Cocozza

Federico Cocozza

Auto-generated profile, based on publicly available information

Federico Cocozza

INSERM U932, Institut Curie Centre de Recherche, PSL Research University, Paris, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2023 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
YFYé Fan
Yé Fan
PPPionneau PIONNEAU
Pionneau PIONNEAU
FCFederico Cocozza
Federico Cocozza
PBPierre-Yves Boelle
Pierre-Yves Boelle
SCSolenne Chardonnet
Solenne Chardonnet
EREric Rubinstein
Eric Rubinstein
The tetraspanins CD9, CD81 and CD63 are major components of extracellular vesicles (EVs). Yet, their impact on EV composition remains under‐investigated. In the MCF7 breast cancer cell line CD63 was as expected predominantly intracellular. In contrast CD9 and CD81 strongly colocalized at the plasma membrane, albeit with different ratios at different sites, which may explain a higher enrichment of CD81 in EVs. Absence of these tetraspanins had little impact on the EV protein composition as analysed by quantitative mass spectrometry. We also analysed the effect of concomitant knock‐out of CD9 and CD81 because these two tetraspanins play similar roles in several cellular processes and associate directly with two Ig domain proteins, CD9P‐1/EWI‐F/PTGFRN and EWI‐2/IGSF8. These were the sole proteins significantly decreased in the EVs of double CD9‐ and CD81‐deficient cells. In the case of EWI‐2, this is primarily a consequence of a decreased cell expression level. In conclusion, this study shows that CD9, CD81 and CD63, commonly used as EV protein markers, play a marginal role in determining the protein composition of EVs released by MCF7 cells and highlights a regulation of the expression level and/or trafficking of CD9P‐1 and EWI‐2 by CD9 and CD81.

28 December 2020 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
PDF file
FCFederico Cocozza
Federico Cocozza
NNNathalie Névo
Nathalie Névo
EPEster Piovesana
Ester Piovesana
XLXavier Lahaye
Xavier Lahaye
JBJulian Buchrieser
Julian Buchrieser
LMLorena Martin‐Jaular
Lorena Martin‐Jaular
SARS‐CoV‐2 entry is mediated by binding of the spike protein (S) to the surface receptor ACE2 and subsequent priming by host TMPRSS2 allowing membrane fusion. Here, we produced extracellular vesicles (EVs) exposing ACE2 and demonstrate that ACE2‐EVs are efficient decoys for SARS‐CoV‐2 S protein‐containing lentivirus. Reduction of infectivity positively correlates with the level of ACE2, is much more efficient than with soluble ACE2 and further enhanced by the inclusion of TMPRSS2.

19 April 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MTMercedes Tkach
Mercedes Tkach
JTJessie Thalmensi
Jessie Thalmensi
ETEleonora Timperi
Eleonora Timperi
PGPaul Gueguen
Paul Gueguen
NNNathalie Névo
Nathalie Névo
CTClotilde Théry
Clotilde Théry
Significance: Our work uncovers mechanisms by which tumor cells impact tumor-associated macrophages in human triple-negative breast cancer. Via extracellular vesicles (EVs), these tumors promote macrophages with proinflammatory features, correlated with better clinical outcome. Our results suggest exploration of these EVs as tools, alone, or in combination with other therapies, to promote a favorable environment for the generation of anti-tumor immune responses.

11 December 2023 in The EMBO Journal
Verified
Journal Article
Open access
FCFederico Cocozza
Federico Cocozza
LMLorena Martin‐Jaular
Lorena Martin‐Jaular
LLLien Lippens
Lien Lippens
ACAurelie Di Cicco
Aurelie Di Cicco
YAYago A. Arribas
Yago A. Arribas
CTClotilde Théry
Clotilde Théry
Cells secrete extracellular vesicles (EVs) and non-vesicular extracellular (nano)particles (NVEPs or ENPs) that may play a role in intercellular communication. Tumor-derived EVs have been proposed to induce immune priming of antigen presenting cells or to be immuno-suppressive agents. We suspect that such disparate functions are due to variable compositions in EV subtypes and ENPs. We aimed to characterize the array of secreted EVs and ENPs of murine tumor cell lines. Unexpectedly, we identified virus-like particles (VLPs) from endogenous murine leukemia virus in preparations of EVs produced by many tumor cells. We established a protocol to separate small EVs from VLPs and ENPs. We compared their protein composition and analyzed their functional interaction with target dendritic cells. ENPs were poorly captured and did not affect dendritic cells. Small EVs specifically induced dendritic cell death. A mixed large/dense EV/VLP preparation was most efficient to induce dendritic cell maturation and antigen presentation. Our results call for systematic re-evaluation of the respective proportions and functions of non-viral EVs and VLPs produced by murine tumors and their contribution to tumor progression.

8 July 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
FCFederico Cocozza
Federico Cocozza
EPEster Piovesana
Ester Piovesana
NNNathalie Névo
Nathalie Névo
XLXavier Lahaye
Xavier Lahaye
JBJulian Buchrieser
Julian Buchrieser
LMLorena Martin-Jaular
Lorena Martin-Jaular
SARS-CoV-2 entry is mediated by binding of the spike protein (S) to the surface receptor ACE2 and subsequent priming by TMPRRS2 allowing membrane fusion. Here, we produced extracellular vesicles (EVs) exposing ACE2 and demonstrate that ACE2-EVs are efficient decoys for SARS-CoV-2 S protein-containing lentivirus. Reduction of infectivity positively correlates with the level of ACE2, is 500 to 1500 times more efficient than with soluble ACE2 and further enhanced by the inclusion of TMPRSS2.

7 April 2026
Verified
Thesis
Closed access
FCFederico Cocozza
Federico Cocozza
Détermination du potentiel des sous-types de vésicules et de particules extracellulaires comme porteurs de protéines en vue de futures applications thérapeutiques: Les vésicules extracellulaires (VEs) et autres nanoparticules extracellulaires (ENP) sont sécrétées par les cellules dans le milieu extracellulaire et ont été identifiées comme des médiateurs importants de la communication avec d'autres cellules et la matrice extracellulaire qui les entoure. Les VEs contiennent diverses molécules, y compris des protéines, qui peuvent délivrer des signaux pour induire des changements physiologiques chez les cellules réceptrices. Du fait de cette propriété de communication intercellulaire particulière, les VEs sont activement étudiées pour éventuellement être utilisées à des fins thérapeutiques. Dans ce travail, nous avons cherché à comparer les fonctions de différents sous-types de VEs, des particules extracellulaires non VEs, et des protéines dans deux contextes pathologiques différents : l'infection virale et les réponses immunitaires anti-tumorales. Premièrement, nous avons évalué les VEs exprimant à leur surface une protéine recombinante reconnue par un virus, le SARS-CoV-2, par rapport à la même protéine non associée aux VEs, pour servir de leurre au virus, et ainsi réduire l'infection. Deuxièmement, nous avons séparé et comparé les sous-types de VEs dérivées de tumeurs, y compris les rétrovirus endogènes, et d'autres particules extracellulaires, pour leur capacité à transférer un antigène et à moduler l'activation des cellules présentatrices d'antigènes. Nos résultats illustrent l'importance d'identifier le(s) sous-type(s) de particule(s) portant la fonction d'intérêt, dans l'optique d'optimiser de futures utilisations de VEs à visée thérapeutique.